Prior treatment status: impact on the efficacy and safety of teriflunomide in multiple sclerosis
Abstract Background In this pooled, post hoc analysis of a phase 2 trial and the phase 3 TEMSO, TOWER, and TENERE clinical trials, long-term efficacy and safety of teriflunomide were assessed in subgroups of patients with relapsing multiple sclerosis (MS) defined by prior treatment status. Methods P...
Na minha lista:
| Principais autores: | , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2020-10-01
|
| coleção: | BMC Neurology |
| Assuntos: | |
| Acesso em linha: | http://link.springer.com/article/10.1186/s12883-020-01937-4 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
